Benjamin Mullish

Cited by

	All	Since 2019
Citations	5429	5240
h-index	37	37
i10-index	77	75

1400

700

350

1050

20162017201820192020202120222023202417 37 96 309 745 1145 1248 1306 447

Public access

View all

108 articles

15 articles

available

not available

Based on funding mandates

Co-authors

Mark ThurszProfessor of Hepatology, Imperial CollegeVerified email at imperial.ac.uk
Julie A. K. McDonaldImperial College LondonVerified email at imperial.ac.uk
Roberta Forlano, MD, PhDClinical research fellow, Imperial college LondonVerified email at imperial.ac.uk
Pinelopi ManousouConsultant at Imperial College Healthcare NHS Trust and Hon Associate Professor at ILDH, UCLVerified email at IMPERIAL.AC.UK
Jonathan SegalUniversity of MelbourneVerified email at nhs.net
Alexandros Pechlivanis, Ph.DResearch Associate, Aristotle University of ThessalonikiVerified email at chem.auth.gr
Jesus Miguens BlancoPostdoctoral fellowVerified email at stanford.edu
Mohammed Nabil QuraishiSheikh Shakhbout Medical City and University of Birmingham Microbiome Treatment CentreVerified email at bham.ac.uk
Dina KaoUniversity of AlbertaVerified email at ualberta.ca
Zain Kassam MD, MPHFinch TherapeuticsVerified email at mail.harvard.edu
Gianluca IaniroGastroenterology Unit - Catholic University, "A. Gemelli" University Hospital, Rome, ItalyVerified email at icatt.it
Monika FischerAssociate Professor of MedicineVerified email at iu.edu
Simon GoldenbergGuy's and St Thomas' NHS Foundation TrustVerified email at gstt.nhs.uk
Colleen KellyBrigham and Women's Hospital; Harvard Medical SchoolVerified email at bwh.harvard.edu
Elaine HolmesMurdoch University & Imperial College LondonVerified email at imperial.ac.uk
Rohma GhaniImperial College LondonVerified email at doctors.org.uk
Giovanni CammarotaProfessore associato, Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli, Roma, ItaliaVerified email at unicatt.it
Antonio GasbarriniProfessor of Gastroenterology, Catholic University, Gemelli Hospital, Rome, ItalyVerified email at iol.it
Tanya MonaghanClinical Associate Professor in Gastroenterology, University of NottinghamVerified email at nottingham.ac.uk
Alexandros T. TzallasAssociate Professor, Department of Informatics & Telecommunications, University of Ioannina, GreeceVerified email at uoi.gr

Benjamin Mullish

Imperial College London/ Imperial College Healthcare NHS Trust

Verified email at imperial.ac.uk - Homepage

Gastroenterology Hepatology Microbiota Metabonomics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019	380	2019
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of … BH Mullish, MN Quraishi, JP Segal, VL McCune, M Baxter, GL Marsden, ... Gut 67 (11), 1920-1941, 2018	360	2018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of … BH Mullish, MN Quraishi, JP Segal, VL McCune, M Baxter, GL Marsden, ... Journal of Hospital Infection 100 (Supplement 1), S1-S31, 2018	355	2018
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications JR Allegretti, BH Mullish, C Kelly, M Fischer The Lancet 394 (10196), 420-431, 2019	288	2019
Effects of fecal microbiota transplantation with oral capsules in obese patients JR Allegretti, Z Kassam, BH Mullish, A Chiang, M Carrellas, J Hurtado, ... Clinical Gastroenterology and Hepatology 18 (4), 855-863. e2, 2020	227	2020
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection BH Mullish, JAK McDonald, A Pechlivanis, JR Allegretti, D Kao, GF Barker, ... Gut 68 (10), 1791-1800, 2019	218	2019
Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance J Glen, L Floros, C Day, R Pryke Bmj 354, 2016	194	2016
Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial JR Allegretti, Z Kassam, M Carrellas, BH Mullish, JR Marchesi, ... Official journal of the American College of Gastroenterology\| ACG 114 (7 …, 2019	185	2019
Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an updated systematic review and meta-analysis SMD Baunwall, MM Lee, MK Eriksen, BH Mullish, JR Marchesi, ... EClinicalMedicine 29, 2020	171	2020
Clostridium difficile infection and antibiotic-associated diarrhoea BH Mullish, HRT Williams Clinical Medicine 18 (3), 237, 2018	169	2018
Optimized sample handling strategy for metabolic profiling of human feces J Gratton, J Phetcharaburanin, BH Mullish, HRT Williams, M Thursz, ... Analytical chemistry 88 (9), 4661-4668, 2016	163	2016
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel G Ianiro, BH Mullish, CR Kelly, H Sokol, Z Kassam, SC Ng, M Fischer, ... The lancet Gastroenterology & hepatology 5 (5), 430-432, 2020	162	2020
Inhibiting growth of Clostridioides difficile by restoring valerate, produced by the intestinal microbiota JAK McDonald, BH Mullish, A Pechlivanis, Z Liu, J Brignardello, D Kao, ... Gastroenterology 155 (5), 1495-1507. e15, 2018	159	2018
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic G Ianiro, BH Mullish, CR Kelly, Z Kassam, EJ Kuijper, SC Ng, TH Iqbal, ... Gut 69 (9), 1555-1563, 2020	143	2020
Depression and the use of antidepressants in patients with chronic liver disease or liver transplantation BH Mullish, MS Kabir, MR Thursz, A Dhar Alimentary pharmacology & therapeutics 40 (8), 880-892, 2014	120	2014
High-throughput, machine learning–based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease R Forlano, BH Mullish, N Giannakeas, JB Maurice, N Angkathunyakul, ... Clinical Gastroenterology and Hepatology 18 (9), 2081-2090. e9, 2020	107	2020
Antibiotic therapy and outcome from immune-checkpoint inhibitors DJ Pinato, D Gramenitskaya, DM Altmann, RJ Boyton, BH Mullish, ... Journal for immunotherapy of cancer 7, 1-8, 2019	98	2019
Functional microbiomics: evaluation of gut microbiota-bile acid metabolism interactions in health and disease BH Mullish, A Pechlivanis, GF Barker, MR Thursz, JR Marchesi, ... Methods 149, 49-58, 2018	98	2018
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms P Fessas, LA Possamai, J Clark, E Daniels, C Gudd, BH Mullish, ... Immunology 159 (2), 167-177, 2020	90	2020
A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being DR Michael, AA Jack, G Masetti, TS Davies, KE Loxley, J Kerry-Smith, ... Scientific reports 10 (1), 4183, 2020	83	2020

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors